Author:
Hayashi Takaaki,Kameya Shuhei,Mizobuchi Kei,Kubota Daiki,Kikuchi Sachiko,Yoshitake Kazutoshi,Mizota Atsushi,Murakami Akira,Iwata Takeshi,Nakano Tadashi
Abstract
AbstractChoroideremia (CHM) is an incurable progressive chorioretinal dystrophy. Little is known about the natural disease course of visual acuity in the Japanese population. We aimed to investigate the genetic spectrum of the CHM gene and visual acuity outcomes in 24 CHM patients from 16 Japanese families. We measured decimal best-corrected visual acuity (BCVA) at presentation and follow-up, converted to logMAR units for statistical analysis. Sanger and/or whole-exome sequencing were performed to identify pathogenic CHM variants/deletions. The median age at presentation was 37.0 years (range, 5–76 years). The mean follow-up interval was 8.2 years. BCVA of the better-seeing eye at presentation was significantly worsened with increasing age (r = 0.515, p < 0.01), with a high rate of BCVA decline in patients > 40 years old. A Kaplan–Meier survival curve suggested that a BCVA of Snellen equivalent 20/40 at follow-up remains until the fifties. Fourteen pathogenic variants, 6 of which were novel [c.49 + 5G > A, c.116 + 5G > A, p.(Gly176Glu, Glu177Ter), p.Tyr531Ter, an exon 2 deletion, and a 5.0-Mb deletion], were identified in 15 families. No variant was found in one family only. Our BCVA outcome data are useful for predicting visual prognosis and determining the timing of intervention in Japanese patients with CHM variants.
Funder
Grant-in-Aid for Scientific Research
Japanese Retinitis Pigmentosa Society
Japan Agency for Medical Research and Development
The Jikei University Research Fund
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Cremers, F. P., van de Pol, D. J., van Kerkhoff, L. P., Wieringa, B. & Ropers, H. H. Cloning of a gene that is rearranged in patients with choroideraemia. Nature 347, 674–677 (1990).
2. Sankila, E. M., Tolvanen, R., van den Hurk, J. A., Cremers, F. P. & de la Chapelle, A. Aberrant splicing of the CHM gene is a significant cause of choroideremia. Nat. Genet. 1, 109–113 (1992).
3. van den Hurk, J. A. et al. Detection and characterization of point mutations in the choroideremia candidate gene by PCR-SSCP analysis and direct DNA sequencing. Am. J. Hum. Genet. 50, 1195–1202, (1992).
4. Seabra, M. C., Brown, M. S. & Goldstein, J. L. Retinal degeneration in choroideremia: Deficiency of rab geranylgeranyl transferase. Science 259, 377–381 (1993).
5. Preising, M. & Ayuso, C. Rab escort protein 1 (REP1) in intracellular traffic: A functional and pathophysiological overview. Ophthal. Genet. 25, 101–110 (2004).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献